New Share Alert: Shandong Xinde Technology's Hong Kong IPO Filing Has Now Expired

Stock News

Aug 17

Financial news reports that Shandong Xinde Technology Co., Ltd., known as Xinde Technology, has seen its Hong Kong IPO prospectus, submitted on February 16, 2026, lapse after a six-month period, becoming invalid as of August 16, 2026. At the time of filing, ICBC International and CITIC Securities International served as its joint sponsors.

According to the prospectus, Xinde Technology was founded in 1999 and is a leading animal health company in China. The firm focuses on the research, development, production, and sales of a full range of animal health and related products, including veterinary biologics (such as vaccines, antibodies, and transfer factors), traditional Chinese veterinary medicine, chemical pharmaceutical preparations, animal feed, and feed additives. These products aim to prevent, diagnose, treat, and control diseases in poultry, livestock, aquatic animals, and pets.

Based on data from Frost & Sullivan, by 2024 revenue, Xinde Technology ranked as the ninth-largest domestic manufacturer in China's animal health market and was among the top three players in the Chinese poultry veterinary biologics market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1161148012"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161148012\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161148012?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 11:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161148012","market":"hk","top_or_hot":-1,"title":"New Share Alert: Shandong Xinde Technology's Hong Kong IPO Filing Has Now Expired","media":"Stock News","content":"<p>Financial news reports that <b>Shandong Xinde Technology Co., Ltd.</b>, known as <b>Xinde Technology</b>, has seen its Hong Kong IPO prospectus, submitted on February 16, 2026, lapse after a six-month period, becoming invalid as of August 16, 2026. At the time of filing, <b>ICBC International</b> and <b>CITIC Securities International</b> served as its joint sponsors.<br><br>According to the prospectus, <b>Xinde Technology</b> was founded in 1999 and is a leading animal health company in China. The firm focuses on the research, development, production, and sales of a full range of animal health and related products, including veterinary biologics (such as vaccines, antibodies, and transfer factors), traditional Chinese veterinary medicine, chemical pharmaceutical preparations, animal feed, and feed additives. These products aim to prevent, diagnose, treat, and control diseases in poultry, livestock, aquatic animals, and pets.<br><br>Based on data from <b>Frost & Sullivan</b>, by 2024 revenue, <b>Xinde Technology</b> ranked as the ninth-largest domestic manufacturer in China's animal health market and was among the top three players in the Chinese poultry veterinary biologics market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Share Alert: Shandong Xinde Technology's Hong Kong IPO Filing Has Now Expired</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Share Alert: Shandong Xinde Technology's Hong Kong IPO Filing Has Now Expired\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-17 11:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Financial news reports that <b>Shandong Xinde Technology Co., Ltd.</b>, known as <b>Xinde Technology</b>, has seen its Hong Kong IPO prospectus, submitted on February 16, 2026, lapse after a six-month period, becoming invalid as of August 16, 2026. At the time of filing, <b>ICBC International</b> and <b>CITIC Securities International</b> served as its joint sponsors.<br><br>According to the prospectus, <b>Xinde Technology</b> was founded in 1999 and is a leading animal health company in China. The firm focuses on the research, development, production, and sales of a full range of animal health and related products, including veterinary biologics (such as vaccines, antibodies, and transfer factors), traditional Chinese veterinary medicine, chemical pharmaceutical preparations, animal feed, and feed additives. These products aim to prevent, diagnose, treat, and control diseases in poultry, livestock, aquatic animals, and pets.<br><br>Based on data from <b>Frost & Sullivan</b>, by 2024 revenue, <b>Xinde Technology</b> ranked as the ninth-largest domestic manufacturer in China's animal health market and was among the top three players in the Chinese poultry veterinary biologics market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IPOS","symbol_name":"Renaissance International IPO ETF","start_time":0,"source_url":"","article_id":"1161148012","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161148012","pubTimestamp":1786935653,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Financial news reports that Shandong Xinde Technology Co., Ltd., known as Xinde Technology, has seen its Hong Kong IPO prospectus, submitted on February 16, 2026, lapse after a six-month period,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IPOS":"Renaissance International IPO ETF","KCE":"SPDR KBW Capital Markets ETF","BK4127":"投资银行业与经纪业","VXUS":"国际股票ETF-Vanguard","FRHC":"Euronext CAC Health Care","KCAI":"KraneShares China Alpha Index ETF","BK4588":"碎股","REDS":"RPM Republican Senate ETF","BK4585":"ETF&股票定投概念"},"translate_title":"新股警报：山东信德科技香港IPO申请现已到期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KCAI":1,"FRHC":1,"REDS":1,"IPOS":1,"KCE":1,"VXUS":1},"content_text":"Financial news reports that Shandong Xinde Technology Co., Ltd., known as Xinde Technology, has seen its Hong Kong IPO prospectus, submitted on February 16, 2026, lapse after a six-month period, becoming invalid as of August 16, 2026. At the time of filing, ICBC International and CITIC Securities International served as its joint sponsors.According to the prospectus, Xinde Technology was founded in 1999 and is a leading animal health company in China. The firm focuses on the research, development, production, and sales of a full range of animal health and related products, including veterinary biologics (such as vaccines, antibodies, and transfer factors), traditional Chinese veterinary medicine, chemical pharmaceutical preparations, animal feed, and feed additives. These products aim to prevent, diagnose, treat, and control diseases in poultry, livestock, aquatic animals, and pets.Based on data from Frost & Sullivan, by 2024 revenue, Xinde Technology ranked as the ninth-largest domestic manufacturer in China's animal health market and was among the top three players in the Chinese poultry veterinary biologics market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}